Daniel Ryweck

Daniel Ryweck

Director of Finance/CFO at SILO PHARMA, INC.

Net worth: 9 750 $ as of 30/03/2024

59 year
Health Technology
Finance
Consumer Services

Profile

Daniel E.
Ryweck
is currently the Controller at Mill City Ventures III Ltd.
since 2020 and the Chief Financial Officer at Silo Pharma, Inc. since 2022.
Previously, he served as the Director at Dala Petroleum Corp.
from 2016 to 2017, the Director at KonaTel, Inc. from 2016 to 2017, and the Chief Financial Officer at Panbela Therapeutics, Inc. in 2015.
Mr. Ryweck obtained his undergraduate degree from The Curtis L.
Carlson School of Management in 1990.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
22/03/2024 5,000 ( 0.18% ) 9 750 $ 30/03/2024

Daniel Ryweck active positions

CompaniesPositionStart
MILL CITY VENTURES III, LTD. Comptroller/Controller/Auditor 31/12/2019
SILO PHARMA, INC. Director of Finance/CFO 26/09/2022
All active positions of Daniel Ryweck

Former positions of Daniel Ryweck

CompaniesPositionEnd
KONATEL, INC. Director/Board Member 30/08/2017
Director/Board Member 30/08/2017
PANBELA THERAPEUTICS, INC. Director of Finance/CFO 31/08/2015
See the detail of Daniel Ryweck's experience

Training of Daniel Ryweck

The Curtis L. Carlson School of Management Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel Ryweck's experience

Connections

35

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
MILL CITY VENTURES III, LTD.

Finance

SILO PHARMA, INC.

Health Technology

PANBELA THERAPEUTICS, INC.

Health Technology

KONATEL, INC.

Communications

Private companies1

Energy Minerals

See company connections